Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_assertion type Assertion NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_head.
- NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_assertion description "[Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_provenance.
- NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_assertion evidence source_evidence_literature NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_provenance.
- NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_assertion SIO_000772 18391076 NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_provenance.
- NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_assertion wasDerivedFrom befree-20140225 NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_provenance.
- NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_assertion wasGeneratedBy ECO_0000203 NP396998.RALqafoJMrB0rwJ-7j2vf6-56quUk7lXok4ARsCmCeraI130_provenance.